Literature DB >> 15318974

An approach to venous thromboembolism prophylaxis in laparoscopic Roux-en-Y gastric bypass surgery.

M Todd Miller1, Peter F Rovito.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) prophylaxis regimens for laparoscopic Roux-en-Y gastric bypass (LRYGBP) have not been adequately addressed in the literature. This study presents the results of our prophylactic regimen in LRYGBP at a tertiary care hospital.
METHODS: A retrospective review of 255 morbidly obese patients undergoing LRYGBP between March 2000 and February 2003 was conducted. Patients received preoperative subcutaneous heparin (SQH) (5000u or 7500u) and every 8 hours thereafter during hospitalization. Sequential compression devices (SCD) were utilized during and after surgery unless ambulating. Early ambulation was enforced.
RESULTS: 255 patients underwent LRYGBP, with 5 (1.9%) converted to open. Average preoperative weight and body mass index (BMI) were 138 kg and 50, respectively. Operative time averaged 174 minutes. Average length of stay was 2.2 days. 9 patients (3.6%) had a prior history of deep venous thrombosis/pulmonary embolism (DVT/PE), one of whom had a DVT/PE postoperatively. 2 patients developed DVT/PE within 30 days. Overall DVT/PE incidence was 1.2%. There were 6 postoperative bleeding episodes (2.4%).
CONCLUSION: This regimen provides excellent prophylaxis against VTE in the hospital setting.

Entities:  

Mesh:

Year:  2004        PMID: 15318974     DOI: 10.1381/0960892041590944

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  20 in total

1.  A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic Procedure.

Authors:  Gurvinder S Jammu; Rajni Sharma
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

Review 2.  Deep venous thrombosis prophylaxis in laparoscopy: an evidence-based review.

Authors:  William S Richardson; Keith Apelgren; Robert D Fanelli; David Earle
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

3.  Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery.

Authors: 
Journal:  Surg Endosc       Date:  2007-04-05       Impact factor: 4.584

4.  Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery.

Authors:  William Richardson; Keith Apelgren; David Earle; Robert Fanelli
Journal:  Surg Endosc       Date:  2007-08-22       Impact factor: 4.584

5.  Practice patterns in high-risk bariatric venous thromboembolism prophylaxis.

Authors:  Howard I Pryor; Adam Singleton; Elissa Lin; Paul Lin; Khashayar Vaziri
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

6.  The long-term risk of venous thromboembolism following bariatric surgery.

Authors:  Kimberley Eden Steele; Michael A Schweitzer; Gregory Prokopowicz; Andrew D Shore; Lisa C B Eaton; Anne O Lidor; Martin A Makary; Jeanne Clark; Thomas H Magnuson
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

7.  Post discharge prophylactic anticoagulation in gastric bypass patient-how safe?

Authors:  Peter Ojo; Bolanle Asiyanbola; Elmer Valin; Randolph Reinhold
Journal:  Obes Surg       Date:  2008-04-03       Impact factor: 4.129

8.  Retrievable inferior vena cava filters in high-risk patients undergoing bariatric surgery.

Authors:  Khashayar Vaziri; Parag Bhanot; Eric S Hungness; Mark D Morasch; Jay B Prystowsky; Alexander P Nagle
Journal:  Surg Endosc       Date:  2009-01-28       Impact factor: 4.584

9.  Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.

Authors:  Brea O Rowan; David A Kuhl; Marilyn D Lee; David S Tichansky; Atul K Madan
Journal:  Obes Surg       Date:  2007-12-29       Impact factor: 4.129

10.  Medical complications of obesity and optimization of the obese patient for colorectal surgery.

Authors:  Nell Maloney Patel; Manish S Patel
Journal:  Clin Colon Rectal Surg       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.